Crossmark

Bioelectronic modulation of carotid sinus nerve activity in the rat: a potential therapeutic approach for type 2 diabetes

Crossref DOI link: https://doi.org/10.1007/s00125-017-4533-7

Published Online: 2018-01-14

Published Print: 2018-03

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Sacramento, Joana F.

Chew, Daniel J.

Melo, Bernardete F.

Donegá, Matteo

Dopson, Wesley

Guarino, Maria P.

Robinson, Alison

Prieto-Lloret, Jesus

Patel, Sonal

Holinski, Bradley J.

Ramnarain, Nishan

Pikov, Victor

Famm, Kristoffer

Conde, Silvia V.
Funding

Funding for this research was provided by:

Fundação para a Ciência e a Tecnologia (PD/BD/105890/2014)

Galvani Bioelectronics
License Information

Text and Data Mining valid from 2018-01-14
More Information

Article History

Received: 5 September 2017

Accepted: 20 November 2017

First Online: 14 January 2018

Duality of interest

: The sponsor (Galvani Bioelectronics, former GlaxoSmithKline Bioelectronics R&D) was involved in the collection, analysis and interpretation of data, as well as in writing the report. SVC has received funding for research support from GlaxoSmithKline Bioelectronics R&D. DJC, NR, VP and WD are employees of Galvani Bioelectronics. AR is employee of GlaxoSmithKline. SP and BJH have been employees of GlaxoSmithKline.